Immunopharmacology of new xenobiotic immunosuppressive molecules.
Morris
R E
RE
Department of Cardiothoracic Surgery, Stanford University School of Medicine, CA 94305-5247.
D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D006084:Graft Rejection / Q000188:drug therapy*; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D012263:Ribonucleosides / Q000494:pharmacology; D020123:Sirolimus; D016559:Tacrolimus / Q000494:pharmacology; D015262:Xenobiotics / Q000494:pharmacology*; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D006146:Guanidines; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011090:Polyenes; D012263:Ribonucleosides; D020123:Sirolimus; D016559:Tacrolimus; D015262:Xenobiotics; C010052:mizoribine; C046943:brequinar; D011798:Quinaldines; C037258:gusperimus